Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)
Clinical trial NCT02662920 · COMPLETED
Trial details
- NCT number
- NCT02662920
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-08-01
- Primary completion
- 2014-04-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.